Rep. Michael Burgess (R-Texas) this week cited ongoing 340B contract pharmacy litigation in cautioning against amending federal spending legislation to rebuke six drug manufacturers’ denials of 340B pricing when covered entities use contract pharmacies.
Key GOP Congressman Opposed 340B Amendment to Spending Bill During Committee Hearing
An influential Republican congressman on Monday cautioned against amending federal spending legislation to rebuke six drug manufacturers’ denials of 340B pricing when covered entities use contract pharmacies.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
